Evidence map›Paper›PMID 40827685›Full record

ArticleBiology of reproduction2026

Identifying established human placental markers of schizophrenia in rodents after gestational ∆9-tetrahydrocannabinol exposure†.

Andrea M Kocsis, Enzo Perez-Valenzuela, Mar Rodríguez-Ruiz, Mohammed H Sarikahya, Anubha Dembla, David R C Natale, Steven R Laviolette, Daniel B Hardy

Abstract read
In one paragraph

Article in Biology of reproduction, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrea M KocsisDepartment of Physiology and Pharmacology, London, Ontario, Canada.
Enzo Perez-ValenzuelaDepartment of Anatomy and Cell Biology, London, Ontario, Canada.
Mar Rodríguez-RuizDepartment of Anatomy and Cell Biology, London, Ontario, Canada.
Mohammed H SarikahyaDepartment of Anatomy and Cell Biology, London, Ontario, Canada.
Anubha DemblaDepartment of Physiology and Pharmacology, London, Ontario, Canada.
David R C NataleDepartment of Obstetrics and Gynaecology, Queen's University, Kingston, Ontario, Canada.
Steven R LavioletteDepartment of Anatomy and Cell Biology, London, Ontario, Canada.
Daniel B HardyDepartment of Physiology and Pharmacology, London, Ontario, Canada.ORCID 0000-0001-5445-273X

Funding

NIMH Center Repository Supporting Stem Cell ResearchU24MH068457 · NIMH · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI BRZUSTOWICZ, LINDA M, KNOWLES, JAMES A · 2003 to 2024
$213.8M
NIMH NIH HHS U24 MH068457
6 · The paper itself

Abstract

Placental complications resulting in fetal growth restriction have been associated with dysregulated placental gene expression tied to an increased risk of schizophrenia. In rat offspring, it has been demonstrated that ∆9-tetrahydrocannabinol exposure in pregnancy results in fetal growth restriction and schizophrenia-like phenotypes (e.g., decreased pre-pulse inhibition of the acoustic startle response). However, it remains elusive if prenatal ∆9-tetrahydrocannabinol exposure induces this schizophrenia signature of placental gene expression. Therefore, our objective was to determine if these established predictive markers of schizophrenia are altered in a preclinical model of gestational oral ∆9-tetrahydrocannabinol exposure in rodents. We observed significantly reduced fetal weights in male and female prenatal ∆9-tetrahydrocannabinol-exposed offspring in the absence of maternal pregnancy outcomes. Placentae from ∆9-tetrahydrocannabinol-exposed males and females revealed altered expression of genes previously identified in human transcriptomic datasets of schizophrenia (i.e., Furin, Rccd1, and Atp5mk), with some expression changes being sex-specific (i.e., Eif5, Rps10, Vps33b, and Iqgap1). A subset of these genes were found differentially expressed in human BeWo cells exposed to ∆9-tetrahydrocannabinol. Targets were next examined in the adult rodent (postnatal day70) brain, and a subgroup of these genes (i.e., Furin, Rps10, and Rccd1) were increased concomitant with schizophrenia-like behavior (e.g., decreased pre-pulse inhibition). We further detected ∆9-tetrahydrocannabinol-induced upregulation of FURIN in patient-derived cerebral organoids, an effect observed in both control and schizophrenia cell lines. Collectively, these findings demonstrate prenatal ∆9-tetrahydrocannabinol exposure can lead to altered gene expression in established prioritized markers of schizophrenia in the placenta in both animal and human models.

Indexed as

DronabinolPlacentaPrenatal Exposure Delayed EffectsSchizophreniaAnimalsBiomarkersFemaleHumansMalePregnancyRatsBiomarkersDronabinolcannabisDOHaDfetal growth restrictionplacentaschizophrenia (SCZ)Δ9-tetrahydrocannabinol (THC)

Identifiers

PMID40827685
PMCPMC12808552

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.